Etiology and Incidence of Moderate-to-Severe Diarrhea in Young Children in Niger

被引:13
作者
Platts-Mills, James A. [1 ]
Houpt, Eric R. [1 ]
Liu, Jie [1 ]
Zhang, Jixian [1 ]
Guindo, Ousmane [2 ]
Sayinzoga-Makombe, Nathan [2 ]
McMurry, Timothy L. [3 ]
Elwood, Sarah [1 ]
Langendorf, Celine [4 ]
Grais, Rebecca F. [4 ]
Isanaka, Sheila [4 ,5 ,6 ]
机构
[1] Univ Virginia, Div Infect Dis & Int Hlth, POB 801340, Charlottesville, VA 22908 USA
[2] Epictr, Niamey, Niger
[3] Univ Virginia, Dept Publ Hlth Sci, Charlottesville, VA USA
[4] Epictr, Dept Res, Paris, France
[5] Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA USA
[6] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA USA
基金
比尔及梅琳达.盖茨基金会;
关键词
children; Cryptosporidium; diarrhea; rotavirus; Shigella; ROTAVIRUS VACCINE; SEASONALITY; EFFICACY;
D O I
10.1093/jpids/piab080
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background. High-resolution data on the etiology of childhood diarrhea in countries with the highest burden and mortality remain sparse and are needed to inform burden estimates and prioritize interventions. Methods. We tested stool specimens collected between October 2014 and December 2017 from children under 2 years of age from the per-protocol population of a placebo-controlled clinical trial of a bovine rotavirus pentavalent vaccine (Rotasiil) in Niger. We tested 1729 episodes of moderate-to-severe diarrhea (Vesikari score >= 7) using quantitative PCR and estimated pathogen-specific burdens by age, season, severity, and trial intervention arm. Results. The 4 pathogens with the highest attributable incidence of diarrhea were Shigella (7.2 attributable episodes per 100 child-years; 95% confidence interval: 5.2, 9.7), Cryptosporidium (6.5; 5.8, 7.2), rotavirus (6.4; 5.9, 6.7), and heat-stabile toxinproducing enterotoxigenic Escherichia coli (ST-ETEC) (6.2; 3.1, 7.7). Cryptosporidium was the leading etiology of severe diarrhea (Vesikari score >= 11) and diarrhea requiring hospitalization. Shigella was the leading etiology of diarrhea in children 12-23 months of age but also had a substantial burden in the first year of life, with 60.5% of episodes of severe shigellosis occurring in infants. Shigella, Cryptosporidium, and ST-ETEC incidence peaked during the warmer and wetter period and coincided with peak all-cause diarrhea incidence. Conclusions. In this high-burden setting, the leading diarrheal pathogens were Shigella, Cryptosporidium, rotavirus, and ST-ETEC, and each was disproportionately seen in infants. Vaccine development should target these pathogens, and the impact of vaccine schedule on diarrhea burden in the youngest children will need to be considered.
引用
收藏
页码:1062 / 1070
页数:9
相关论文
共 50 条
  • [31] Cytokine plasma levels in moderate-to-severe asthmatic children with different asthma control
    Smirnova, Svetlana
    Gorbacheva, Nina
    Belenyuk, Vasiliy
    Zobova, Svetlana
    Smolnikova, Marina
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [32] Biologicals for moderate-to-severe plaque type psoriasis in pediatric patients
    Libon, Florence
    Lebas, Eve
    De Schaetzen, Virginie
    Sabatiello, Murielle
    De Schepper, Sofie
    Nikkels, Arjen F.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2021, 17 (09) : 947 - 955
  • [33] Causative pathogens of severe diarrhea in children
    Ismaeel, AY
    Jamsheer, AE
    Yousif, AQ
    Al-Otaibi, MA
    Botta, GA
    SAUDI MEDICAL JOURNAL, 2002, 23 (09) : 1064 - 1069
  • [34] Stunting Following Moderate-to-Severe Diarrhea Among Children Aged <5 Years in Africa Before and After Rotavirus Vaccine Introduction: A Comparison of the Global Enteric Multicenter Study and the Vaccine Impact on Diarrhea in Africa (VIDA) Study
    Nasrin, Dilruba
    Liang, Yuanyuan
    Verani, Jennifer R.
    Powell, Helen
    Sow, Samba O.
    Omore, Richard
    Hossain, M. Jahangir
    Doh, Sanogo
    Zaman, Syed M. A.
    Jones, Joquina Chiquita M.
    Awuor, Alex O.
    Kasumba, Irene N.
    Tennant, Sharon M.
    Ramakrishnan, Usha
    Kotloff, Karen L.
    CLINICAL INFECTIOUS DISEASES, 2023, 76 : S49 - S57
  • [35] Comparison of Ustekinumab and Etanercept for Moderate-to-Severe Psoriasis
    Griffiths, Christopher E. M.
    Strober, Bruce E.
    van de Kerkhof, Peter
    Ho, Vincent
    Fidelus-Gort, Roseanne
    Yeilding, Newman
    Guzzo, Cynthia
    Xia, Yichuan
    Zhou, Bei
    Li, Shu
    Dooley, Lisa T.
    Goldstein, Neil H.
    Menter, Alan
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (02) : 118 - 128
  • [36] Biologic treatment sequences in moderate-to-severe psoriasis
    Ting, Samantha
    Lowe, Patricia
    Smith, Annika
    Fernandez-Penas, Pablo
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2024, 65 (07) : e178 - e186
  • [37] Postural mechanisms in moderate-to-severe cerebral palsy
    Goodworth, Adam
    Saavedra, Sandra
    JOURNAL OF NEUROPHYSIOLOGY, 2021, 125 (05) : 1698 - 1719
  • [38] Treating patients with moderate-to-severe psoriasis vulgaris
    Kessler, Timothy R.
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2022, 35 (03): : 28 - 35
  • [39] Lebrikizumab for the Treatment of Moderate-to-Severe Atopic Dermatitis
    Bernardo, Diana
    Bieber, Thomas
    Torres, Tiago
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2023, 24 (05) : 753 - 764
  • [40] Abrocitinib for the Treatment of Moderate-to-Severe Atopic Dermatitis
    Villegas, Susan C.
    Dima, Lorena
    AMERICAN JOURNAL OF THERAPEUTICS, 2023, 30 (02) : E117 - E125